Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
van der Sijde F, Azmani Z, Besselink MG, Bonsing BA, de Groot JWB, Groot Koerkamp B, Haberkorn BCM, Homs MYV, van IJcken WFJ, Janssen QP, Lolkema MP, Luelmo SAC, Mekenkamp LJM, Mustafa DAM, van Schaik RHN, Wilmink JW, Vietsch EE, van Eijck CHJ. van der Sijde F, et al. Among authors: vietsch ee. Ther Adv Med Oncol. 2021 Aug 18;13:17588359211033704. doi: 10.1177/17588359211033704. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34422118 Free PMC article.
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
van der Sijde F, Homs MYV, van Bekkum ML, van den Bosch TPP, Bosscha K, Besselink MG, Bonsing BA, de Groot JWB, Karsten TM, Groot Koerkamp B, Haberkorn BCM, Luelmo SAC, Mekenkamp LJM, Mustafa DAM, Wilmink JW, van Eijck CHJ, Vietsch EE, On Behalf Of The Dutch Pancreatic Cancer Group. van der Sijde F, et al. Among authors: vietsch ee. Int J Mol Sci. 2021 Oct 9;22(20):10902. doi: 10.3390/ijms222010902. Int J Mol Sci. 2021. PMID: 34681562 Free PMC article.
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.
van der Sijde F, Dik WA, Mustafa DAM, Vietsch EE, Besselink MG, Debets R, Koerkamp BG, Haberkorn BCM, Homs MYV, Janssen QP, Luelmo SAC, Mekenkamp LJM, Oostvogels AAM, Smits-Te Nijenhuis MAW, Wilmink JW, van Eijck CHJ; Dutch Pancreatic Cancer Group. van der Sijde F, et al. Among authors: vietsch ee. Front Immunol. 2022 Aug 25;13:898498. doi: 10.3389/fimmu.2022.898498. eCollection 2022. Front Immunol. 2022. PMID: 36091056 Free PMC article.
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction.
van Eijck CWF, Strijk G, Vietsch EE, van der Sijde F, Verheij M, Mustafa DAM, Vink M, Aerts JGJV, van Eijck CHJ, Willemsen M. van Eijck CWF, et al. Among authors: vietsch ee. Eur J Cancer. 2024 Jan;196:113440. doi: 10.1016/j.ejca.2023.113440. Epub 2023 Nov 17. Eur J Cancer. 2024. PMID: 37988843 Free article.
23 results